LTBR and diabetes mellitus: Early treatment with LTβR‐Ig in non‐obese diabetic (NOD) mice prevents insulitis and insulin‐dependent diabetes mellitus, and LTβR‐Ig treatment at a late stage of insulitis also dramatically reverses insulitis and prevents diabetes 12, 13, 14.